Ashraf A. Tabll

Egypt Center for Research and Regenerative Medicine — Egypt

Medicine · Health Sciences

22h-index1.4kcitations117works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(55), Hepatitis B Virus Studies(37), Liver Disease Diagnosis and Treatment(36), Monoclonal and Polyclonal Antibodies Research(19), Hepatocellular Carcinoma Treatment and Prognosis(9)

Publications117 total

Editorial: Advancements in antibody-based immunotherapy and cancer vaccines for hepatocellular carcinoma
Frontiers in Immunology·2025Open Access
A virus-like-particle-producing DNA vaccine triggers specific humoral immunity against hepatitis C virus in mice
Archives of Virology·2025
Emerged SARS-CoV-2 intermediate hosts: The missing links from One Health perspective
Journal of King Saud University - Science·2025Open Access
Insights into antiviral activity of chlorpromazine against RNA viruses: Molecular docking, ADME profile, and semi-in vivo study
Journal of Virological Methods·2025
Evaluation of hyaluronic acid and type III procollagen peptide as predictors for treatment response to direct-acting antivirals
World Journal of Virology·2025Open Access
Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches
Frontiers in Immunology·2025Open Access
Review Article: Egyptian Efforts to Control Hepatitis C Virus in Egypt
Alfarama Journal of Basic & Applied Sciences·2025· 2 citedOpen Access
Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt
BMC Biotechnology·2025· 4 citedOpen Access
Molecular Basis for Hepatocellular Carcinoma Development in Low/Middle-Income Countries
2025Open Access
Correction: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia
Microbial Cell Factories·2024Open Access
Review Article: Blood Proteins as Potent Biomarkers for Colorectal Carcinoma
Alfarama Journal of Basic & Applied Sciences·2024Open Access
Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Virology Journal·2024Open Access
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Virology Journal·2024· 3 citedOpen Access
Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development
Virology·2024· 3 cited
Serum collagen IV as a predictor for response to direct-acting antivirals hepatitis C therapy
Journal of Immunoassay and Immunochemistry·2024
Serum thymosin beta 10 level as a potential prognosis prediction of hepatocellular carcinoma and hepatic diseases.
PubMed·2024
Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model
Current Issues in Molecular Biology·2024· 8 citedOpen Access
Immunogenicity study of a Novel DNA-Based HCV vaccine candidate.
PubMed·2024
Development and characterization of three novel mouse monoclonal antibodies targeting spike protein S1 subunit of Middle East respiratory syndrome corona virus
Human Antibodies·2024
Investigating the Association Between Epstein-Barr Virus and Hepatocellular Carcinoma in Egyptian Patients
Biochemistry Letters·2024Open Access
page 1 of 6Next →

Frequent Co-authors

Mostafa K. El Awady(14), Yasmine S. El(12), Abdelfattah M. Attallah(12), Noha G. Bader El Din(11), Reem El‐Shenawy(10), Robert Smolić(9), Martina Smolić(9), Hisham Ismail(8), Mohamed M. Omran(6), Elrashdy M. Redwan(4), Naglaa Zayed(4), Moataza H Omran(4), Ana G. Petrovic(4), Mohamed Elsadany(4), Samir El‐Masry(4), Ibrahim El‐Dosoky(4), Tawfeek H. Abdelhafez(3), Samar Samir Youssef(3), Gamal Esmat(3), Amr Helmy(3)